Rainbow Rare Earths Phalaborwa project shaping up to be one of the lowest cost producers globally. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,599.00
Bid: 1,594.50
Ask: 1,595.50
Change: -19.00 (-1.17%)
Spread: 1.00 (0.063%)
Open: 1,608.00
High: 1,615.00
Low: 1,575.00
Prev. Close: 1,618.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

EU mergers and takeovers (Jan 28)

Wed, 28th Jan 2015 18:21

BRUSSELS, Jan 28 (Reuters) - The following are mergers underreview by the European Commission and a brief guide to the EUmerger process:

APPROVALS AND WITHDRAWALS

-- Generic drugmaker Mylan Inc to purchase AbbotLaboratories' specialty and branded generics businessoutside the United States (approved Jan. 28)

-- Swiss drugmaker Novartis to acquire Britishpeer GlaxoSmithKline's oncology products (approved Jan.28)

-- British drugmaker GlaxoSmithKline to acquireNovartis' vaccines business, excluding flu, and thesetting up of a consumer healthcare joint venture (approved Jan.28)

NEW LISTINGS

None

EXTENSIONS AND OTHER CHANGES

None

FIRST-STAGE REVIEWS BY DEADLINE

JAN 28

-- French chemicals producer Arkema to purchaseBlu-Tack maker Bostik from French oil major Total (notified Dec. 12/deadline Jan. 28)

FEB 5

-- Belgian telecoms group Telenet to acquire 50percent stake in Belgian broadcasting company De Vijver Media(notified Aug. 18/deadline extended for the second time to March5 from Feb. 5)

FEB 9

-- Proposed joint venture for 1 gigawatt "Nemo" power linkbetween Belgium and Britain between Britain's National Grid and Belgium's transmission system operator Elia (notified Jan. 5/deadline Feb. 9/simplified)

FEB 12

-- European private equity firm CVC Capital Partners to buy Finnish insulation material maker Paroc for enterprise value of some 700 million euros.(notified Jan. 8/deadline Feb. 12)

FEB 13

-- German conglomerate Siemens to purchase U.S.oilfield equipment maker Dresser-Rand Group Inc (notified Jan. 9/deadline Feb. 13)

-- Japanese building materials and housing equipment groupLIXIL Group Corp to take sole control of sanitoryfittings group Grohe (notified Jan. 9/deadline Feb13/simplified)

FEB 16

-- Private equity firm Bain Capital to acquire Britishbrickmaker Ibstock Group from Irish buidling supplies group CRH (notified Jan. 12/deadline Feb. 16/simplified)

FEB 17

-- Private equity firm Apax Partners to acquire ScandinavianIT services provider Evry (notified Jan. 13/deadline Feb.17/simplified)

FEB 18

-- Canadian asset manager Brookfield Infrastructure Fund to acquire broadcasting and wireless telecominfrastructure platform operator TDF S.A.S.(notified Jan.14/deadline Feb. 18/simplified)

FEB 19

-- Swiss telecoms provider Swisscom and carleasing company Sixt to set up a joint venture (notified Jan.15/deadline Feb. 19/simplified)

FEB 20

-- French minerals company Imerys to acquire rivalS&B Minerals (notified Jan. 15/deadline Feb. 20)

FEB 23

-- U.S. conglomerate General Electric to acquire mostof French engineering group Alstom's power equipmentbusiness (notified Jan. 19/deadline Feb. 23)

-- Commodities trader Cargill to buy rival ArcherDaniels Midland Co's global chocolate business (notifiedJan. 19/deadline Feb. 23)

-- German DIY retailer OBI to acquire a joint venture led byBrico Business Cooperation (notified Jan. 19/deadline Feb.23/simplified)

FEB 25

-- Asset manager The Carlyle Group and private equityfirm Warburg Pincus to jointly acquire control of creditrating agency DBRS Holdings (notified Jan. 21/deadline Feb.25/simplified)

FEB 26

-- German car parts maker ZF Friedrichshafen to buyU.S. peer TRW Automotive Holdings Corp (notified Jan.22/deadline Feb. 26)

FEB 27

-- Canadian private equity firm Onex Corp toacquire aseptic filler machines maker SIG Combibloc Group AG and SIG Holding USA (notified Jan. 23/deadline Feb.27/simplified)

MARCH 5

-- Belgian telecoms group Telenet, which is asubsidiary of U.S. cable group Liberty Global, toacquire 50 percent stake in Belgian broadcasting company DeVijver Media (notified Aug. 18/deadline extended for the secondtime to March 5 from Feb. 5/companies submitted concessions onNov. 24)

APRIL 22

-- SOCAR, Azerbaijan's state energy company, to buy stakesin Greek natural gas grid operator DESFA from Greek natural gasutility DEPA (notified Oct. 1/deadline extended for the secondtime to April 22 from March 23)

APRIL 30

-- French telecoms operator Orange to acquireSpanish provider Jazztel (notified Oct. 16/deadlineextended to April 30 from April 24 after the Commission resumedits scrutiny after a four-day halt)

MAY 13

-- Mondelez International Inc and competitor D.EMaster Blenders to merge their coffee businesses innew company called Jacobs Douwe Egberts (notified Oct.27/deadline extended for the third time to May 13 from May 6)

MAY 29

-- PRS for Music Ltd (PRSfM), Foreningen Svenska TonsattaresInternationella Mysikbyra (Stim) and Gesellschaft fürmusikalische Aufführungs- und mechanischeVervielfältigungsrechte (Gema) to set up a joint venture toadminister mechanical and performing rights (notified Nov.28/deadline extended to May 29 from Jan. 14 after the Commissionopened an in-depth probe)

SUSPENDED

-- U.S. orthopaedic products maker Zimmer Holdings to acquire rival Biomet Inc (notified Aug.29/deadline suspended from Dec. 2, 2014)

GUIDE TO EU MERGER PROCESS

DEADLINES:

The European Commission has 25 working days after a deal is filed for a first-stage review. It may extend that by 10 workingdays to 35 working days, to consider either a company's proposedremedies or an EU member state's request to handle the case.

Most mergers win approval but occasionally the Commission opens a detailed second-stage investigation for up to 90 additional working days, which it may extend to 105 working days.

SIMPLIFIED:

Under the simplified procedure, the Commission announces theclearance of uncontroversial first-stage mergers without givingany reason for its decision. Cases may be reclassified asnon-simplified - that is, ordinary first-stage reviews - untilthey are approved. (Editing by Foo Yun Chee)

More News
4 Apr 2024 00:03

Sanofi to settle 4,000 Zantac cancer lawsuits in US state courts

NEW YORK, April 3 (Reuters) - Sanofi has reached an agreement in principle to settle 4,000 U.S. lawsuits linking the discontinued heartburn drug Zantac to cancer, the company said on Wednesday.

Read more
3 Apr 2024 22:01

Biden, Senator Bernie Sanders push companies to cut cost of asthma inhalers, prescription drugs

WASHINGTON, April 3 (Reuters) - President Joe Biden hosted a White House event with U.S. Senator Bernie Sanders on Wednesday to tout their fight against high prescription drug prices and push companies to cut the cost of inhalers for asthma sufferers.

Read more
3 Apr 2024 21:37

What to know about bird flu in dairy cows and the risk to humans

CHICAGO, April 3 (Reuters) - Texas officials reported on Monday that a farm worker tested positive for H5N1, or bird flu, that has spread to dairy cows in Texas, Kansas, New Mexico, Michigan and Idaho - the first time the virus has infected cattle.

Read more
19 Mar 2024 09:21

LONDON BROKER RATINGS: Investec cuts ConvaTec; RBC raises Vistry

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

Read more
18 Mar 2024 12:00

GSK unveils promising results from endometrial cancer trial

(Sharecast News) - GSK unveiled promising outcomes from a phase three trial of 'Jemperli', or dostarlimab, in treating primary advanced or recurrent endometrial cancer on Monday.

Read more
18 Mar 2024 08:47

TOP NEWS: Pfizer launches GBP2 billion sale of 8% stake in Haleon

(Alliance News) - Haleon PLC on Monday said Pfizer Inc plans to sell around GBP2 billion in Haleon shares, some of which will be bought back by Haleon.

Read more
18 Mar 2024 08:47

GSK says Jemperli combination gets good results for endometrial cancer

(Alliance News) - GSK PLC on Monday said a test of its Jemperli drug in combination with chemotherapy has shown it reduced the risk of death in patients with endometrial cancer by nearly a third.

Read more
7 Mar 2024 09:38

GSK observes positive data in Blenrep trial for blood cancer treatment

(Alliance News) - GSK PLC on Thursday announced positive results for Blenrep for the treatment of multiple myeloma.

Read more
7 Mar 2024 07:21

GSK reports more encouraging trial results for Blenrep

(Sharecast News) - GSK unveiled encouraging results from its 'DREAMM-8' phase three trial on Thursday, comparing the efficacy of 'Blenrep', or belantamab mafodotin, in combination with pomalidomide plus dexamethasone, or PomDex, against the standard treatment of bortezomib plus PomDex in relapsed or refractory multiple myeloma patients.

Read more
5 Mar 2024 11:03

GSK says ViiV's cabotegravir study supports longer HIV dose interval

(Alliance News) - GSK PLC on Tuesday celebrated study results from ViiV Healthcare Ltd, that showed an investigational formulation of cabotegravir can be dosed at four-month intervals.

Read more
5 Mar 2024 07:26

GSK's ViiV upbeat on ultra-long-acting HIV treatment study

(Sharecast News) - GSK announced on Tuesday that its specialist GIV joint venture with Pfizer and Shionogi, ViiV Healthcare, had reported encouraging results from its phase one clinical trial of an investigational formulation of cabotegravir, termed cabotegravir ultra long-acting (CAB-ULA).

Read more
29 Feb 2024 09:44

TOP NEWS: GSK avoids "protracted litigation" with Zantac settlement

(Alliance News) - GSK PLC on Thursday emphasised its commitment to science, as it reached another settlement in ongoing litigation over alleged links between its heartburn drug and cancer.

Read more
29 Feb 2024 07:22

GSK reaches settlement in another Zantac case

(Sharecast News) - GSK announced a confidential settlement with Boyd/Steenvoord, effectively resolving a case filed in California state court over its discontinued heartburn drug Zantac.

Read more
26 Feb 2024 08:25

GSK gonorrhoea treatment achieves efficacy endpoint in latest trial

(Alliance News) - GSK PLC on Monday announced positive results from the latest trial of its oral gonorrhoea treatment, showing it to be on par with intramuscular therapies.

Read more
26 Feb 2024 07:22

GSK reports positive results from gonorrhoea treatment trial

(Sharecast News) - GSK announced encouraging headline outcomes from its trial of gepotidacin, an oral antibiotic aiming to address uncomplicated urogenital gonorrhoea in adolescents and adults, on Monday.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.